M&A Deal Summary

Cerba HealthCare Acquires lifebrain

On July 21, 2021, Cerba HealthCare acquired healthcare services company lifebrain from Investindustrial

Acquisition Highlights
  • This is Cerba HealthCare’s 1st transaction in the Healthcare Services sector.
  • This is Cerba HealthCare’s 1st transaction in Austria.

M&A Deal Summary

Date 2021-07-21
Target lifebrain
Sector Healthcare Services
Buyer(s) Cerba HealthCare
Sellers(s) Investindustrial
Deal Type Add-on Acquisition

Target

lifebrain

Vienna, Austria
lifebrain is a medical diagnostic laboratory group with several laboratories in Italy and Switzerland pursuing a buy-and-build strategy focused on consolidation in the laboratory diagnostics sector. lifebrain AG was established in 2013 and is based in Vienna, Austria.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cerba HealthCare

Issy-les-Moulineaux, France

Category Company
Founded 1967
Sector Healthcare Services
Employees4,300
Revenue 630M EUR (2016)
DESCRIPTION

Cerba HealthCare is an operator of clinical pathology laboratories, with a number one position in France and strong market positions in Belgium and Luxembourg. The majority of Cerba's revenues are generated via routine lab tests. Cerba HealthCare was founded in 1967 and is based in Issy-les-Moulineaux, France.


DEAL STATS #
Overall 4 of 5
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 4 of 5
Country (Austria) 1 of 1
Year (2021) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Accolab Laboratories

Issy-les-Moulineaux, France

Accolab Laboratories is a group of eight clinical laboratories located in the area of Bordeaux, Lyon and in Spain. Accolab offers a comprehensive medical diagnostics offering, combining medical biology and anatomocytopathology. Accolab Laboratories was founded in 2010 and is based in Issy-les-Moulineaux, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-16 ViroClinics

Rotterdam, Netherlands

ViroClinics is a virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics’ extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. ViroClinics was founded in 2001 and is based in Rotterdam, Netherlands.

Buy -

Seller(S) 1

SELLER

Investindustrial

London, United Kingdom

Investor Investor


Category Private Equity Firm
Founded 1990
PE ASSETS 11.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Investindustrial is an investment firm focused on creating global leaders through organic growth and acquisitions. The Firm is operationally driven and seeks opportunities in Southern Europe. Areas of interest include services, consumer, retail, leisure, and industrial manufacturing. Investindustrial has offices in London, Luxembourg, Milan, Lugano, Barcelona, Shanghai, and New York.


DEAL STATS #
Overall 31 of 34
Sector (Healthcare Services) 3 of 3
Type (Add-on Acquisition) 15 of 16
Country (Austria) 1 of 1
Year (2021) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-01 Guala Closures

Alessandria, Italy

Guala Closures is a manufacturer of spirits and wine closures through operating in 5 continents with 27 production sites and has a commercial presence in over 100 countries; about 90% of the group's turnover is generated outside of Italy. Guala Closures was founded in 1954 and is based in Alessandria, Italy.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-01 Rimac Automobili

Sveta Nedelja, Croatia

Rimac Automobili designs, develops and manufactures the Nevera an, all-electric hypercar, the fastest accelerating car in the world (quarter-mile in 8.9 seconds, 0-100 km/h in 1.97 seconds), with over 1,900 horsepower and a top speed of more than 400 km/h. Rimac has completed a combination of its hypercar business with Bugatti, the high-performance brand belonging to the Volkswagen group. Rimac Automobili was founded in 2009 and is based in Sveta Nedelja, Croatia.

Buy -